| 000 | 01234nam a2200337 a 4500 | ||
|---|---|---|---|
| 001 | vtls000071084 | ||
| 003 | KUKTEM | ||
| 005 | 20251125095403.0 | ||
| 008 | 130607t2013 njua f b 001 0 eng d | ||
| 020 | _a9781118354599 (ebk.) | ||
| 020 | _a1118354591 (ebk.) | ||
| 020 | _a9781118354575 (ebk.) | ||
| 020 | _a1118354575 (ebk.) | ||
| 020 | _a9781118354582 | ||
| 020 | _a1118354583 | ||
| 020 | _a9781118354568 | ||
| 020 | _a1118354567 | ||
| 020 | _a9780470646274 (cloth) | ||
| 039 | 9 |
_a201411131455 _bazhar _c201312190957 _djamie _y201306071212 _zirma |
|
| 040 | _aUMP | ||
| 090 | _aRM301.4 .F87 2013 f | ||
| 245 | 1 | 0 |
_aFusion protein technologies for biopharmaceuticals : _bapplications and challenges / _ceditor by Stefan R. Schmidt |
| 260 |
_aHoboken, N. J. : _bJohn Wiley & Sons, _cc2013 |
||
| 300 |
_axxviii, 624 p. : _bill. (some col.) ; _c29 cm. |
||
| 504 | _aIncludes bibliographical references and index | ||
| 650 | 0 | _aBiopharmaceutics | |
| 650 | 0 | _aPharmaceutical biotechnology | |
| 650 | 0 |
_aRecombinant Fusion Proteins _xtherapeutic use |
|
| 700 | 1 | _aSchmidt, Stefan R. | |
| 999 |
_aVIRTUA40 _c70861 _d70867 |
||
| 999 | _aVTLSSORT0080*0200*0201*0202*0203*0204*0205*0206*0207*0208*0400*0900*2450*2600*3000*5040*6500*6501*6502*7000*9992 | ||